Pulmonary Rehabilitation and Quality of Life

December 30, 2019 updated by: Yeliz Ciğerci, Afyonkarahisar Health Sciences University

The Effect of Pulmonary Rehabilitation on Respiratory Functions and Quality of Life Following Coronial Artery Bypass Grafting: a Randomized Controlled Trial

In this study, the effect of a pulmonary rehabilitation (PR) program on the respiratory function and quality of life of patients undergoing CABG surgery with an open-heart technique is examined. A randomized controlled experimental design was used. The study was conducted with two groups: the intervention group (n=25) and control group (n=25). The control group received standard care after CABG. In contrast, the experimental group, in addition to standard care, participated in a PR program created by the researchers. After CABG, the respiratory functions of both groups (clinical care day 4) and quality of life (6th week) evaluated

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Centre
      • Afyonkarahisar, Centre, Turkey, 03200
        • Afyonkarahisar Health Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who were extubated in twenty-four hours,
  • aged 18 or above,
  • had undergone CABG surgery using the open-heart method and using a saphenous vein graft for CABG,
  • who were conscious,
  • without visual and hearing problems,
  • who spoke Turkish,
  • had not orthopedic, psychiatric and neurological problems,
  • no co-morbid lung disease,
  • who had not been re-operated on,
  • had not postoperative cardiac dysfunction,
  • had not developed postoperative atrial fibrillation,
  • who were willing to participate in the study.

Exclusion Criteria:

  • Patients who were not extubated in twenty-four hours,
  • who were under 18 years of age,
  • had not undergone CABG surgery using the open-heart method and using a saphenous vein graft for CABG,
  • who were not conscious,
  • were visual and hearing problems,
  • who don't spoke Turkish,
  • had orthopedic, psychiatric and neurological problems,
  • co-morbid lung disease,
  • who had been re-operated on,
  • had postoperative cardiac dysfunction,
  • had developed postoperative atrial fibrillation,
  • who were not willing to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group
standard care and participated in a pulmonary rehabilitation program
Simple breathing techniques, secretion-removal techniques, airway-cleaning techniques, mobilization techniques and use of an incentive spirometer
No Intervention: control group
received standard care after coronary artery bypass graft

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Pulmonary Function Test (PFT)
Time Frame: Preoperative day
A diagnostic criterion used to identify patients with or at risk of pulmonary dysfunction. The PFT assessment was performed using the NDD Easy on-PC spirometer. During this test, challenging expiratory volume (FEV1 % (>80)), challenging vital capacity (FVC % (>80)), FEV1/FVC ( %, >80) ratio, and Peak Expiratory air pressure (PEF % (>100)) were measured in the first second. The PFT was performed in the Chest Diseases Outpatient Clinic of the hospital preoperatively.
Preoperative day
The Pulmonary Function Test (PFT) Change
Time Frame: 4th day of clinical care
A diagnostic criterion used to identify patients with or at risk of pulmonary dysfunction. The PFT assessment was performed using the NDD Easy on-PC spirometer. During this test, challenging expiratory volume (FEV1 % (>80)), challenging vital capacity (FVC % (>80)), FEV1/FVC ( %, >80) ratio, and Peak Expiratory air pressure (PEF % (>100)) were measured in the first second. The PFT was performed in the Chest Diseases Outpatient Clinic of the hospital preoperatively. The PFT was performed in the Chest Diseases Outpatient Clinic of the 4th day of clinical care.
4th day of clinical care

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Short-Form Health Survey (SF-36)
Time Frame: preoperative day
The points given vary between 0-100; 0 points indicate bad health and 100 points indicate that health is progressing in a good direction.
preoperative day
The Short-Form Health Survey (SF-36) Change
Time Frame: postoperative sixth week
The points given vary between 0-100; 0 points indicate bad health and 100 points indicate that health is progressing in a good direction.
postoperative sixth week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yeliz Ciğerci, PhD, +90 272 444 0304

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

December 29, 2017

Study Completion (Actual)

December 29, 2017

Study Registration Dates

First Submitted

December 26, 2019

First Submitted That Met QC Criteria

December 27, 2019

First Posted (Actual)

January 2, 2020

Study Record Updates

Last Update Posted (Actual)

January 2, 2020

Last Update Submitted That Met QC Criteria

December 30, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Bypass Graft

Clinical Trials on pulmonary rehabilitation

3
Subscribe